Abstract
International Journal of Pharmacology and Clinical Sciences,2019,8,4,232-236.DOI:10.5530/ijpcs.2019.8.51Published:December 2019Type:Research ArticleAuthors:Yousef Ahmed Alomi, Sultan Mohammed Al-Jarallah, Rasha Abdelsalam Elshenawy, and Faiz A Bahadig Rph Author(s) affiliations:Yousef Ahmed Alomi*, The Former General Manager of General Administration of Pharmaceutical Care, The Former Head, National Clinical Pharmacy and Pharmacy Practice, The Former Head, Pharmacy R & D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. Sultan Mohammed Al-Jarallah, Head, Ambulatory Care Pharmacy, Oncology and Hematology Clinical Pharmacist, Pharmaceutical Care Department, Security Forces Hospital, Riyadh, SAUDI ARABIA. Rasha Abdelsalam Elshenawy, BCS. Pharm. BCPS (AQ-ID), CPHQ, M.Sc., TQM (AUC), SIDP, CEO of FADIC, Ministry of Health, Makkah, SAUDI ARABIA. Faiz A Bahadig Rph, (BSC-Pharm, MBA), Informatics Pharmacist, Pharmaceutical Care Department, King Abdulaziz Medical, City-WR-Jeddah, Ministry of National Guard, SAUDI ARABIA. Abstract:Objective: Ministry of Health (MOH) hospitals in Saudi Arabia should develop, organize and administer a formulary system that follows the principles to optimize patient care by ensuring access to clinically appropriate, safe and cost-effective medications. This can be achieved through the Pharmacy and Therapeutic Committee’s (PTC) role in the evaluation of hospital’s drug formulary and decision-making. The primary purposes of the PTC are policy development, communication and education and formulary management. Therefore, in this study, we aimed to explore the hospital drug formulary evaluation and decision-making at MOH hospitals in Saudi Arabia. Methods: This is a 4-month cross-sectional national survey of PTC at MOH hospitals in Saudi Arabia. The survey consisted of two parts: the first part collected demographic information and the second part consisted on 93 questions divided into four domains. An electronic survey was distributed to all drug information centers at MOH hospitals and analyzed the evaluation of drug formulary and decision-making through the Survey Monkey system. Results: A total of 50 drug information centers responded to the questionnaire (100%). Restricted drug usage (3.88), new drug entities (3.74), new dosage form (3.6) and new strength (3.6) were the majority of the requests for inclusion in the formulary. A total of 1-3 medications were evaluated monthly by the PTC at 41 (82%) hospitals. Most of the healthcare providers were allowed to request for the addition or deletion of medications: PTC members 38 (76%), attending medical staff 35 (70%), pharmacy staff 10 (20%) and formulary subcommittees 10 (20%). The formal economic analysis of the drug formulary revision was rarely or never conducted at 26 (42%) hospitals. The responsible person for the economic evaluation was drug information pharmacist (21 (42%)), pharmacy department (nonspecific) (17 (34%)) and the pharmacy and medical department (14 (28%)). Conclusion: Evaluation of hospital’s drug formulary and decision-making was not adequate at the majority of the hospitals. Education and training about drug evaluation with an emphasis on cost analysis and impact are mandatory. An electronic addition new medications with close formulary is required with close monitoring for all MOH hospitals in Saudi Arabia. Keywords:Decision-Making, Drug Formulary, Evaluation, Ministry of Health, National Pharmacy and Therapeutic Committee, Saudi ArabiaView:PDF (202.48 KB) PDFClick here to download the PDF file. Images The formulary management system.
Highlights
The necessary policies and procedures that govern the Pharmacy and Therapeutic Committee (PTC) are taken care by the administration of the drug formulary system in the healthcare institution
The PTC is responsible for the administration of the drug formulary system
One of the elements of a drug formulary system that should be included is the evaluation of the clinical use of medications
Summary
The necessary policies and procedures that govern the PTCs are taken care by the administration of the drug formulary system in the healthcare institution. The essential organization of each healthcare setting and its medical staff are influenced by the specific functions and scope of the PTC. One of the elements of a drug formulary system that should be included is the evaluation of the clinical use of medications (including outcomes). The development of policies and quality assurance activities for medication use and administration and the evaluation and monitoring of adverse drug reactions ADRs and medication errors should be included. The PTC developed an evidence-based formulary of medications and medication-associated products accepted for use in the organization. The PTC, on an ongoing basis, objectively appraised, evaluated and selected medications for the addition to or deletion from the formulary.[1]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Pharmacology and Clinical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
